AstraZeneca has out licensed worldwide rights to a Phase 3 ready novel chemical entity to Amani Therapeutics. The compound ...
By Pushkala Aripaka and Nithyashree R B March 27 (Reuters) - AstraZeneca's experimental drug tozorakimab reduced flare-ups of ...
WASHINGTON -- The top U.S. infectious disease expert said AstraZeneca's suspension of final testing of its COVID-19 vaccine candidate shows "one of the safety valves" built into the studies to spot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results